Clinical Report: Things You Didn’t Know About SLT
Overview
Revise to emphasize SLT's role in ocular surface health and as a rescue therapy.
Background
SLT has shifted earlier in the glaucoma treatment paradigm, supported by evidence from the LiGHT trial and other studies. This change is crucial as it offers a cost-effective alternative to traditional topical medications, potentially improving patient outcomes. Understanding SLT's applications and addressing common misconceptions can enhance its utilization in clinical practice.
Data Highlights
No numerical data provided in the article.
Key Findings
- SLT is effective as a first-line therapy for glaucoma, offering better long-term disease control compared to medications.
- It can serve as a rescue therapy for patients with ocular surface issues due to medications.
- Patient counseling is critical; framing SLT as a primary option can improve acceptance.
- SLT can be utilized in uveitic eyes with careful management and collaboration with uveitis specialists.
- Topical NSAIDs are generally prescribed post-SLT for primary open-angle glaucoma, while steroids are recommended for uveitic eyes.
Clinical Implications
Clinicians should consider SLT as a primary treatment option for glaucoma, particularly for patients struggling with medication side effects. Effective communication about the benefits of SLT can enhance patient acceptance and adherence to treatment.
Conclusion
Reiterate the need for ongoing education and suggest areas for further training.
Related Resources & Content
- Syril K. Dorairaj, MD, et al., Glaucoma Physician, 2026 -- Things You Didn’t Know About SLT
- Thomas Castillo, DO, MBA, Ophthalmic Professional, 2023 -- Six tips for SLT teamwork
- Nathan M. Radcliffe, MD, Ophthalmology Management, 2016 -- Four common SLT misconceptions
- American Academy of Ophthalmology, ScienceDirect, 2024 -- Selective Laser Trabeculoplasty for the Treatment of Glaucoma
- NICE, Guidance, 2022 -- Recommendations | Glaucoma: diagnosis and management
- Ophthalmology Management — ALT vs. SLT: Is One Better Than the Other?
- Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial
- Advancing glaucoma care: What's new in the 6th edition of the European Glaucoma Society guidelines
- Recommendations | Glaucoma: diagnosis and management | Guidance | NICE
- Selective Laser Trabeculoplasty for the Treatment of Glaucoma: A Report by the American Academy of Ophthalmology - ScienceDirect
- Six-year rate of visual field progression in the Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial
- Checking your browser - reCAPTCHA
- Repeat Selective Laser Trabeculoplasty and Open-Angle Glaucoma | Glaucoma | JAMA Ophthalmology | JAMA Network
- Is Selective Laser Trabeculoplasty Effective in Reducing Intraocular Pressure for Primary Angle-Closure Glaucoma? A Systematic Review and Meta-Analysis - PubMed
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







